Trial Subject Personal Data. The Principal Investigator shall obtain Trial Subject written consent for the collection and use of Trial Subject personal data for Trial purposes as a condition of the Trial Subject participating in the Trial, including the disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with applicable data protection provisions. g. The Institution consents to the disclosure of information required under the European Federation of Pharmaceutical Industries and Associations Code (“EFPIA Code”). The Principal Investigator shall ensure that any member of the Trial research staff provides their consent for the Sponsor to disclose their personal information and any amounts paid to them under this Agreement for the purposes of complying with the EFPIA Code. 12.3
Appears in 1 contract
Sources: Clinical Trial Agreement
Trial Subject Personal Data. The Principal Investigator shall obtain Trial Subject written consent for the collection and use of Trial Subject personal data for Trial purposes as a condition of the Trial Subject participating in the Trial, including the disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with applicable data protection provisions. g. The Institution Provider consents to the disclosure of information required under the European Federation of Pharmaceutical Industries and Associations Code (“EFPIA Code”). The Principal Investigator shall ensure that any member of the Trial research staff Collaborator provides their consent for the Sponsor to disclose their personal information and any amounts paid to them under this Agreement for the purposes of complying with the EFPIA Code. 12.3souhlasu společnosti INC Research nepševede na žádnou tšetí stranu.
Appears in 1 contract
Sources: Clinical Trial Agreement